ProQR Therapeutics (PRQR) Change in Working Capital (2013 - 2026)

ProQR Therapeutics (PRQR) has reported Change in Working Capital for 14 consecutive years, with -$124037.0 the latest figure, recorded in Q1 2026.

• Quarterly Change in Working Capital fell 101.62% year-over-year to -$124037.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (up 355.52% YoY) and the FY2023 annual result came in at -$55.7 million, down 10951.02% from the prior year.
• Change in Working Capital advanced to -$124037.0 in Q1 2026 per PRQR's latest filing, from -$3.5 million in the prior quarter.
• Over the last five years, Change in Working Capital for PRQR reached as high as $59.5 million in Q1 2023 and fell as low as -$108.8 million in Q4 2023.
• A 5-year average of -$3.8 million and a median of $1138.0 in 2022 frame the typical range for Change in Working Capital.
• The largest YoY upside for Change in Working Capital was 5228900.0% in 2023 against a maximum downside of 9320.3% in 2023.
• Year by year, Change in Working Capital stood at -$1.2 million in 2022, then sank by 9320.3% to -$108.8 million in 2023, then soared by 101.17% to $1.3 million in 2024, then plunged by 375.2% to -$3.5 million in 2025, then soared by 96.45% to -$124037.0 in 2026.
• According to Business Quant data, Change in Working Capital over the past three periods registered -$124037.0, -$3.5 million, and $1138.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.